oncolyt
adenovirus
ad
emerg
promis
new
therapi
fight
cancer
adenovirus
famili
nonenvelop
dna
virus
compris
differ
serotyp
organ
speci
viral
capsid
icosahedron
compos
hexon
penton
base
protein
attach
penton
base
fiber
protein
consist
three
region
tail
shaft
knob
region
initi
bind
virus
cell
mediat
interact
viral
fiber
protein
variou
cell
receptor
differ
somewhat
speci
initi
bind
adenovir
speci
undergo
intern
via
engag
integrin
secondari
receptor
cellular
receptor
interact
viral
fiber
protein
extens
studi
cellular
protein
coxsacki
adenoviru
receptor
car
found
main
receptor
implic
bind
adenovir
serotyp
speci
util
car
initi
bind
speci
b
adenovirus
compris
two
subspeci
group
speci
b
virus
associ
infect
varieti
human
organ
system
includ
respiratori
tract
urinari
tract
kidney
eye
discoveri
receptor
util
group
b
adenovirus
prove
quit
challeng
membran
regul
protein
complement
activ
name
found
bind
serotyp
speci
b
adenoviru
marttila
et
al
conclud
use
group
b
serotyp
except
sirena
et
al
demonstr
also
bind
second
receptor
initi
known
receptor
x
later
identifi
cell
adhes
molecul
call
desmoglein
also
implic
initi
bind
also
report
play
role
bind
although
current
thought
less
import
effect
oncolyt
adenovir
therapi
greatli
depend
bind
domain
viral
vector
major
convent
adbas
vector
util
human
adenoviru
type
serotyp
belong
speci
c
adenovirus
genom
well
character
easili
manipul
speci
c
virus
util
car
initi
bind
replicationcompet
cancer
therapeut
effect
cancer
upregul
car
express
unfortun
viral
construct
understand
exhibit
lowefficaci
cardefici
cancer
pancrea
gastric
melanoma
prostat
colon
ovarian
breast
other
overcom
problem
intens
work
done
develop
adbas
vector
undergo
carindepend
entri
one
strategi
remark
improv
oncolyt
potenti
adbas
therapi
involv
format
viral
chimera
design
accommod
structur
compon
differ
viru
serotyp
effect
approach
first
verifi
fiber
knob
replac
knob
subsequ
demonstr
signific
enhanc
viru
bind
entri
sinc
infectivityenhanc
vector
util
speci
b
bind
domain
demonstr
remark
superior
mani
cancer
rel
parent
strain
revolution
field
oncolyt
viru
therapi
although
efficaci
tropismmodifi
chimer
adenovir
vector
clearli
establish
translat
clinic
practic
challeng
due
lack
suitabl
anim
model
mani
differ
model
includ
mice
cotton
rat
rabbit
syrian
hamster
dog
pig
investig
even
partial
support
adenovir
replic
studi
conduct
speci
c
serotyp
type
bind
domain
unabl
find
literatur
directli
test
replic
abil
either
vector
speci
b
adenovir
vector
nonhuman
tissu
surpris
util
differ
cellular
receptor
increas
oncolyt
efficaci
well
known
human
adenoviru
effect
transduc
wide
rang
nonhuman
cell
line
tend
produc
product
viral
progeni
human
cell
standard
murin
model
gener
consid
nonpermiss
host
small
anim
includ
rabbit
woodchuck
guinea
pig
also
show
poor
abil
support
effect
replic
singl
studi
report
replic
vector
canin
cell
although
result
thu
far
reproduc
extens
search
appropri
anim
model
support
human
adenovir
replic
led
identif
two
import
speci
cotton
rat
syrian
hamster
cotton
rat
shown
multipl
studi
semipermiss
human
adenovir
infect
oncolyt
effect
demonstr
anim
model
widespread
use
hamper
difficult
speci
work
limit
commerci
avail
syrian
hamster
emerg
essenti
anim
model
evalu
speci
c
serotyp
anim
studi
extens
known
support
replic
immunecompet
model
enabl
evalu
ad
behavior
situ
natur
host
immun
respons
hamster
use
conduct
preclin
toxic
studi
mani
adenovir
vector
capac
speci
vital
resourc
bring
adenovir
treatment
clinic
trial
attempt
made
use
syrian
hamster
preclin
model
retarget
vector
despit
prior
use
model
evalu
tropismmodifi
virus
abil
hamster
support
replic
speci
b
retarget
vector
directli
test
pig
wide
use
field
biomed
research
similar
human
anatomi
physiolog
genet
howev
serious
investig
test
oncolyt
adenovir
vector
last
two
decad
group
studi
porcin
cell
line
replic
jogler
et
al
took
experi
evalu
vivo
show
evid
effect
replic
pig
studi
provid
promis
data
limit
earli
time
point
use
demonstr
product
viral
replic
use
singl
anim
group
vivo
studi
difficulti
expens
work
larg
anim
commerci
avail
cell
line
limit
wide
accept
model
field
matur
mani
new
chimer
vector
creat
may
benefici
pursu
model
help
make
jump
clinic
translat
studi
set
test
variou
nonhuman
model
includ
mice
syrian
hamster
dog
pig
replic
potenti
vector
demonstr
among
test
nonhuman
cell
line
porcin
cell
support
bind
replic
adenovir
vector
vivo
studi
immunocompet
yorkshir
pig
confirm
pig
valid
preclin
model
evalu
perform
replic
compet
vector
hope
data
help
foster
clinic
translat
oncolyt
adenovirus
includ
speci
b
retarget
tropism
first
set
evalu
viral
bind
vector
nonhuman
cell
line
viral
bind
quantifi
use
viruscel
bind
assay
cell
infect
viru
incub
prevent
viral
intern
total
cell
dna
analyz
pcr
determin
amount
bound
viral
dna
express
dna
copi
per
ng
dna
bind
event
mous
hamster
canin
porcin
cell
line
compar
human
lung
adenocarcinoma
use
receptor
posit
control
figur
wherea
infect
result
similar
level
bind
activ
test
nonhuman
human
cell
line
infect
vari
remark
speci
name
bind
viru
murin
approxim
lower
respect
compar
human
p
p
respect
viral
dna
copi
number
hamster
cell
lower
p
canin
cell
show
similar
tendenc
demonstr
significantli
lower
bind
abil
p
porcin
cell
line
cell
demonstr
viral
bind
event
rate
near
human
control
primari
swine
cell
bound
vector
quit
poorli
second
highest
number
bind
event
among
nonhuman
cell
line
behind
cell
notabl
pig
cell
nonhuman
cell
test
show
stronger
bind
vector
vector
pattern
seen
next
test
cell
line
evalu
adenovir
transduct
effici
pair
ident
replic
defici
lucexpress
vector
either
wild
type
fiber
chimer
fiber
use
infect
cell
line
luc
activ
use
measur
gene
transfer
figur
rodent
canin
cell
show
signific
differ
gene
transduct
vector
virus
consist
effect
gene
transfer
murin
demonstr
significantli
lower
level
transgen
express
chimera
lower
p
respect
similarli
hamster
cell
line
show
poor
gene
transfer
luc
activ
lower
respect
rel
note
compar
human
control
four
rodent
cell
line
neglig
luciferas
activ
vector
nearli
order
magnitud
lower
trend
signific
superior
versu
also
observ
canin
cell
convers
porcin
cell
line
demonstr
significantli
increas
transduct
effici
vector
compar
virus
p
addit
rlu
level
porcin
cell
approach
seen
human
cell
determin
whether
test
nonhuman
cell
line
support
viral
replic
infect
cell
replicationcompet
vector
cell
infect
low
titer
viral
particl
vp
cell
day
allow
least
cycl
viru
replic
surviv
cell
stain
crystal
violet
figur
observ
cell
kill
murin
cell
either
vector
hamster
cell
present
evid
replicationmedi
cell
death
infect
vector
howev
observ
cytolysi
infect
canin
cell
resist
viral
cytolysi
viral
construct
stay
intact
entir
durat
porcin
cell
line
demonstr
remark
adenovirusmedi
cell
kill
upon
infect
low
titer
viru
howev
signific
oncolysi
observ
low
titer
counterpart
quantifi
cytolyt
effect
cell
line
plate
infect
vector
titer
vpcell
incub
day
mt
cell
viabil
assay
perform
quantifi
cell
death
figur
murin
cell
kill
infect
particularli
line
show
signific
amount
cell
death
observ
signific
cytolysi
murin
cell
infect
canin
cell
show
signific
cell
death
either
viral
vector
hamster
cell
kill
quit
effici
vector
kill
effect
seen
infect
serotyp
chimer
vector
porcin
cell
kill
vector
latter
effici
counterpart
earlier
time
point
order
demonstr
better
quantifi
replic
abil
adenovir
vector
test
cell
line
next
evalu
replicationdepend
gene
express
porcin
mous
hamster
cell
infect
replicationcompet
vector
luc
gene
place
ad
region
figur
previous
report
vector
structur
express
report
transgen
follow
late
profil
due
control
major
late
promot
therefor
consist
replic
cycl
murin
cell
low
luciferas
activ
infect
either
vector
observ
time
depend
increas
luc
activ
time
indic
lack
viral
replic
hamster
cell
line
demonstr
effect
replicationdepend
gene
express
vector
vp
day
rlu
day
rlu
vp
day
rlu
day
rlu
howev
luc
activ
reach
rel
low
level
cell
infect
virus
vp
day
rlu
vp
day
rlu
porcin
cell
demonstr
replicationdepend
gene
express
infect
virus
infect
porcin
cell
vector
show
particularli
robust
increas
luciferas
activ
time
vp
day
rlu
day
rlu
perform
trend
analysi
evalu
rate
chang
test
cell
line
compar
murin
cell
demonstr
significantli
lower
rate
chang
p
except
cell
infect
vpcell
trend
lower
p
hamster
cell
infect
show
significantli
lower
rate
chang
compar
condit
p
cell
infect
vpcell
significantli
higher
rate
chang
p
unexpect
known
hamster
cell
support
product
viral
replic
vector
assess
porcin
cell
test
anoth
pair
ad
vector
express
human
sodium
iodid
symport
ni
replicationdepend
manner
region
infect
cell
stain
fluorescentconjug
antibodi
ni
ad
hexon
protein
fluoresc
captur
imag
figur
observ
express
ad
hexon
ni
cell
infect
virus
quantit
assess
ni
posit
cell
use
flow
cytometri
analysi
figur
reveal
similar
level
nisposit
cell
day
infect
either
post
infect
give
viru
suffici
time
replic
observ
percentag
nisposit
cell
infect
greater
observ
unmodifi
infect
p
vitro
experi
first
demonstr
abil
porcin
cell
support
replicationdepend
gene
express
associ
vector
even
suggest
superior
vector
assess
swine
preclin
model
studi
replicationcompet
human
adenovir
vector
system
inject
immunocompet
yorkshir
pig
vp
fiberunmodifi
luc
express
replic
viru
liver
biopsi
obtain
day
necropsi
perform
day
major
organ
evalu
viral
infect
seven
day
post
infect
either
vector
adenovir
dna
detect
pig
lung
spleen
dna
figur
viral
dna
quantiti
lung
spleen
correl
well
replicationdepend
luc
express
respect
measur
similar
level
luc
activ
figur
interestingli
unlik
mice
liver
tropism
observ
pig
viral
replic
liver
tissu
almost
neglig
demonstr
much
lower
level
viral
dna
liver
biopsi
earlier
time
point
background
valu
day
post
infect
dna
copi
number
correl
well
luc
express
liver
biopsi
result
confirm
abil
adenovir
vector
activ
replic
live
swine
system
administr
support
use
pig
potenti
model
test
adenovir
vector
includ
speci
bretarget
viral
construct
signific
sign
toxic
observ
either
infect
pig
administr
singl
dose
viral
particl
aspart
aminotransferas
ast
lactat
dehydrogenas
ldh
may
increas
liver
lung
damag
show
elev
group
day
within
refer
interv
return
baselin
day
liver
damag
marker
sorbitol
dehydrogenas
sdh
show
mild
elev
day
group
howev
clinic
relev
alkalin
phosphatas
alp
liver
specif
alanin
aminotransferas
alt
normal
pig
see
tabl
complet
serum
chemistri
profil
individu
pig
microscop
chang
kidney
liver
seen
upon
necropsi
day
post
infect
microscop
chang
limit
lung
includ
interstiti
pneumonia
howev
pneumonia
observ
experiment
control
group
analysi
hematolog
paramet
control
infect
pig
baselin
post
infect
reveal
increas
within
refer
rang
white
blood
cell
neutrophil
monocyt
day
return
baselin
day
tabl
signific
chang
observ
red
blood
cell
platelet
level
oncolyt
adenovir
technolog
matur
engin
tropismmodifi
virus
util
speci
b
bind
domain
emerg
crucial
step
improv
efficaci
convent
vector
retarget
improv
infect
oncolyt
adenovir
therapeut
across
broad
rang
tumor
includ
pancreat
gastric
ovarian
melanoma
esophag
breast
prostat
other
field
move
bring
tropismmodifi
virus
clinic
practic
appropri
current
preclin
anim
model
must
question
speci
b
receptor
permiss
speci
identifi
preclin
toxicolog
studi
requir
adenoviru
replicationpermiss
anim
model
effect
adinduc
cytolysi
immun
respons
evalu
order
pinpoint
potenti
preclin
model
speci
bretarget
ad
perform
compar
analysi
replic
properti
chimer
vector
variou
nonhuman
cell
line
murin
syrian
hamster
canin
porcin
found
littl
evid
product
viral
infect
either
vector
murin
canin
cell
line
addit
tropism
modifi
virus
uniformli
underperform
wild
type
counterpart
speci
immunocompet
syrian
hamster
semipermiss
human
replic
proven
work
well
preclin
evalu
viral
construct
includ
rgdmodifi
vector
interestingli
preclin
studi
begun
use
hamster
model
assess
vector
syrian
hamster
even
though
permiss
hamster
model
tropismmodifi
vector
never
formal
establish
difficulti
establish
anim
model
vector
coupl
known
differ
receptor
felt
essenti
directli
address
syrian
hamster
abil
undergo
product
infect
chimer
serotyp
vector
studi
suggest
syrian
hamster
far
less
permiss
confirm
clear
evid
replic
replicationdepend
cell
death
hamster
cell
similar
result
absent
cell
infect
vector
poor
infect
infect
syrian
hamster
cell
report
literatur
other
suggest
discrep
could
explain
lack
receptor
rodent
cell
inde
group
report
express
mice
rat
limit
test
bind
gene
transfer
assay
directli
assess
viral
entri
demonstr
low
viral
entri
neglig
transduct
effici
hamster
cell
infect
virus
directli
compar
human
control
cell
line
hamster
cell
infect
show
lower
viru
bide
least
lower
transduct
effici
complet
detail
analysi
car
receptor
express
nonhuman
cell
line
need
elucid
reason
lead
differ
infect
howev
due
major
differ
nucleotid
sequenc
speci
singl
primer
antibodi
insuffici
object
compar
receptor
express
pattern
therefor
believ
function
bind
assay
provid
accur
evalu
bind
abil
vector
nonhuman
speci
cell
viabil
replic
assay
show
syrian
hamster
cell
death
virus
compar
construct
express
bind
domain
replic
depend
gene
express
nearli
two
order
magnitud
lower
hamster
cell
infect
virus
express
bind
domain
seri
experi
convincingli
demonstr
syrian
hamster
permiss
host
product
infect
adenovir
vector
anim
provid
meaning
preclin
data
test
cell
line
porcin
cell
nonhuman
cell
demonstr
suscept
infect
tropism
modifi
adenovir
vector
experi
saw
improv
perform
virus
compar
virus
porcin
cell
pattern
mimick
seen
human
control
cell
line
rodent
canin
exhibit
opposit
pattern
construct
outperform
five
vitro
experi
addit
infect
porcin
cell
significantli
effici
express
replic
depend
ni
express
three
time
cell
test
posit
ni
express
vs
cell
note
due
lack
avail
porcin
cancer
cell
line
current
market
porcin
cell
use
normal
noncarcinogen
cell
line
test
repres
malign
human
adenovirus
possess
intrins
select
replic
cancer
tissu
tend
show
increas
viru
infect
toward
malign
cell
vs
normal
cell
level
adenoviru
replic
observ
normal
porcin
cell
comparison
human
control
suggest
malign
porcin
cell
would
support
replic
human
similar
effici
malign
human
cell
vitro
studi
import
first
step
vivo
test
immunocompet
anim
need
truli
evalu
valid
pig
model
administ
virus
express
replicationdepend
luciferas
immunocompet
yorkshir
pig
evalu
viru
distribut
day
post
infect
pcr
analys
viral
dna
reveal
signific
presenc
lung
spleen
anim
dna
copi
number
similar
anim
infect
vector
infect
viral
dna
could
potenti
secondari
sequestr
inocul
viral
particl
actual
viral
replic
examin
tissu
replicationdepend
luciferas
express
pig
tissu
exhibit
pattern
luc
express
highest
level
transgen
seen
lung
spleen
level
gene
express
two
differ
viral
construct
significantli
differ
data
provid
strong
evid
activ
viral
replic
product
function
progeni
versu
simpl
sequestr
viral
inoculum
knowledg
support
feasibl
use
pig
model
studi
speci
b
retarget
adenovirus
adenovirus
wellknown
tropism
liver
rodent
model
interest
discov
similar
phenomenon
pig
studi
addit
day
analysi
liver
biopsi
taken
inject
pig
multipl
time
point
analyz
viral
dna
replicationdriven
luciferas
express
interestingli
level
viral
dna
luc
activ
liver
almost
neglig
throughout
experi
indic
differ
pattern
adenovir
biodistribut
pig
compar
rodent
liver
toxic
observ
pig
despit
high
dose
vp
system
administr
viru
gener
adenovirusinject
pig
remain
good
health
condit
demonstr
adenovirusrel
toxic
addit
studi
multipl
time
point
necessari
elucid
biodistribut
pharmacokinet
system
administ
adenovirus
pig
model
studi
demonstr
flaw
use
syrian
hamster
test
serotyp
chimer
vector
also
first
report
valid
pig
valuabl
model
preclin
test
oncolyt
adenovirus
util
adenoviru
type
receptor
immunocompet
pig
close
mimic
human
anatomi
physiolog
abl
provid
use
inform
biodistribut
toxic
adenovir
vector
may
help
bridg
gap
clinic
translat
cell
line
obtain
american
type
cultur
collect
manassa
va
usa
unless
otherwis
specifi
includ
human
lung
adenocarcinoma
murin
pancreat
adenocarcinoma
hepatoma
syrian
hamster
pancreat
cancer
kind
gift
dr
hollingsworth
univers
nebraska
lincoln
ne
usa
canin
osteosarcoma
canin
melanoma
kind
gift
dr
j
modiano
univers
minnesota
minneapoli
mn
usa
nonmalign
porcin
kidney
epitheli
human
nonhuman
cell
cultur
humidifi
condit
growth
medium
supplement
fetal
bovin
serum
penicillinstreptomycin
maintain
adher
monolay
cultur
dmem
cultur
emem
cell
grown
dmem
supplement
mm
hepe
sigma
st
loui
mo
usa
primari
swine
pancrea
cell
isol
lab
cultur
emem
supplement
fb
ngml
egf
bovin
pituitari
extract
pen
strepampicillin
briefli
swine
pancrea
surgic
remov
pancreat
duct
dissect
free
tissu
duct
digest
mgml
collagenaseiv
trypsin
shake
h
room
temperatur
digest
duct
filter
use
cell
strainer
whole
cell
plate
onto
collagen
coat
dish
pancreat
duct
cell
outgrew
day
coloni
consequ
maintain
subcultur
use
experi
duct
cell
confirm
express
epicam
three
pair
adenoviru
type
chimer
vector
fiber
use
studi
vector
chimer
fiber
compos
shaft
knob
incorpor
describ
previous
bind
kill
assay
use
replicationcompet
wild
type
retarget
counterpart
modifi
fiber
assess
gene
transfer
use
pair
replicationdefici
vector
luciferas
luc
insert
control
cmv
promot
assess
replicationdepend
gene
transfer
use
replic
compet
vector
express
luc
sodium
iodid
symport
ni
respect
viral
vector
construct
base
structur
describ
previous
briefli
delet
nonessenti
gene
within
maintain
adenovir
death
protein
adp
gene
replicationcompet
virus
propag
cell
use
amplifi
replicationdefici
counterpart
viral
vector
purifi
doubl
cscl
densiti
gradient
ultracentrifug
follow
dialysi
phosphatebuff
salin
pb
glycerol
viru
prep
store
aliquot
use
cell
cellswel
grown
well
plate
infect
viral
particl
vp
per
cell
h
prevent
viru
intern
unbound
viru
wash
away
cell
collect
scrape
total
dna
extract
use
qiagen
dna
blood
tissu
kit
qiagen
germantown
md
usa
cat
dna
concentr
determin
use
nanodrop
spectrophotomet
thermofish
minneapoli
mn
usa
pcr
use
primer
gene
use
determin
bound
viru
total
dna
rel
gene
copi
number
sampl
calcul
use
standard
curv
known
concentr
gene
previous
describ
cell
cellswel
grown
well
plate
infect
replicationdefici
ad
express
luciferas
vpcell
h
infect
medium
remov
infect
cell
cultur
appropri
growth
medium
luciferas
activ
repres
rel
light
unit
rlu
determin
post
infect
use
luciferas
assay
kit
per
manufactur
instruct
cat
promega
madison
wi
usa
protein
estim
perform
use
dc
assay
biorad
hercul
ca
usa
cat
data
express
rluper
total
protein
cell
cellswel
grown
well
plate
infect
replic
compet
hour
infect
medium
remov
infect
cell
cultur
appropri
growth
medium
human
mous
hamster
porcin
cell
infect
vp
per
cell
day
cell
fix
buffer
formalin
minut
stain
crystal
violet
ethanol
minut
plate
gentli
rins
tap
water
air
dri
scan
convert
grayscal
adob
photoshop
cell
cellswel
grown
well
plate
infect
replicationcompet
vp
per
cell
fb
contain
infect
medium
post
infect
total
cell
viabil
determin
use
cell
titer
one
solut
cell
prolifer
assay
kit
promega
cat
data
express
live
cell
rel
untreat
control
cell
analysi
luciferas
gene
express
use
replicationcompet
ident
counterpart
mous
hamster
porcin
cell
cultur
wellplat
cellswel
infect
vpcell
h
infect
medium
remov
infect
cell
cultur
appropri
growth
medium
luciferas
activ
assay
untreat
viru
treat
cell
day
postinfect
use
luciferas
assay
kit
describ
data
repres
rel
light
unit
rlu
qualit
analysi
ni
gene
express
use
replic
compet
ident
counterpart
porcin
cell
cultur
chamber
slide
cell
per
well
infect
vpcell
h
unbound
viru
wash
away
cell
fix
paraformaldehyd
solut
fix
cell
permeabil
ice
sigma
chemic
cat
block
bsa
primari
antibodi
incub
overnight
ni
thermo
fisher
scientif
minneapoli
mn
usa
cat
antiadhexon
fitcconjug
millipor
massachusett
usa
cat
mous
antiiggp
conjug
secondari
antibodi
cat
incub
h
room
temperatur
slide
coverslip
dapi
antifad
solut
vector
lab
ca
usa
imag
captur
use
fluoresc
microscop
leica
minneapoli
mn
usa
quantit
analysi
ni
gene
express
use
ni
express
vector
infect
porcin
cell
cultur
well
plate
cell
per
well
infect
vpcell
h
unbound
viru
wash
away
infect
media
replac
fresh
growth
media
cell
collect
scrape
day
post
infect
fix
paraformaldehyd
solut
stain
ni
express
ni
stain
cell
analyz
bd
flow
cytomet
bd
bioscienc
san
jose
ca
usa
data
express
ni
express
cell
event
immunocompet
yorkshir
pig
kg
preanesthet
telazolxylazin
anesthet
nembut
intub
cuf
endotrach
tube
standard
surgic
suit
singl
viral
dose
vp
inject
via
peripher
ear
vein
pig
per
group
control
pig
receiv
pb
contain
glycerol
percutan
liver
biopsi
perform
sedat
pig
truecut
biopsi
needl
analyz
ad
distribut
day
postinfect
day
pig
euthan
beuthansia
liver
lung
spleen
tissu
immedi
harvest
cut
half
center
half
tissu
sampl
fix
buffer
formaldehyd
immunostain
patholog
analysi
second
half
snapfrozen
store
total
dna
extract
mg
tissu
pcr
use
determin
viral
dna
copi
number
indic
viru
distribut
dna
use
standard
curv
known
gene
copi
luciferas
activ
determin
spleen
lung
liver
indic
viral
replic
complet
blood
count
test
cbc
blood
chemistri
analysi
perform
blood
serum
marshfield
laboratori
madison
wi
usa
clinic
patholog
histopatholog
analys
perform
independ
boardcertifi
veterinari
pathologist
experiment
surgic
servic
surgeri
depart
univers
minnesota
minneapoli
mn
usa
statist
analys
vitro
vivo
perform
excel
data
review
function
microsoft
pair
sampl
ttest
use
compar
effect
gene
transfer
assay
human
nonhuman
cell
line
well
porcin
tissu
result
twotail
pvalu
consid
statist
signific
data
present
mean
valu
error
bar
repres
standard
deviat
perform
trend
analysi
replic
depend
gene
express
experi
evalu
rate
chang
test
cell
line
differ
condit
vpcell
vpcell
four
linear
mix
model
virusdos
combin
fit
compar
rate
chang
day
day
among
five
cell
line
condit
model
includ
fix
effect
cell
line
day
interact
random
intercept
includ
sampl
n
per
cell
line
outcom
variabl
log
transform
stabil
varianc
across
multipl
time
measur
comparison
rel
chang
log
rlu
per
day
current
studi
approv
institut
biosafeti
committe
ibc
protocol
id
pi
davydova
julia
institut
anim
care
use
committe
iacuc
protocol
id
studi
demonstr
flaw
use
syrian
hamster
test
serotyp
chimer
vector
also
first
report
valid
pig
valuabl
model
preclin
test
oncolyt
adenovirus
util
adenoviru
type
receptor
hope
data
help
foster
clinic
translat
oncolyt
adenovirus
includ
retarget
tropism
